James Mersch

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Design and synthesis of improved active-site SHP2 inhibitors with anti-breast cancer cell effects”.

Design and synthesis of improved active-site SHP2 inhibitors with anti-breast cancer cell effects

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.115017

N/A

0DataRank · unranked

10 citations

Roxy Nicoletti, James Mersch, Yehenew M. Agazie, Dhanaji M. Lade

Gram-scale synthesis of the thiazolidinedione-based mitoNEET ligand NL-1 using a Hantzsch ester reduction

Tetrahedron Letters(2025)10.1016/j.tetlet.2025.155863

N/A

0DataRank · unranked

1 citations

Yehenew M. Agazie, Michael A. Menze, Mary E. Konkle, Jason D. Huber, Werner J. Geldenhuys +1 more

Development of a more penetrating HER2-positive Breast Cancer Tumor Model and Testing Efficacy of SHP2 Targeting with an Active-Site Inhibitor

Research Square(2025)10.21203/rs.3.rs-8196938/v1

N/A

0DataRank · unranked

0 citations

James Mersch, Dhanaji M. Lade, Paul R. Lockman, Yehenew M. Agazie